Souhaitez-vous accéder aux communiqués récents ?

Received FDA Breakthrough Therapy Designation for AAV2-hAQP1Reported positive three-year data from the Phase 1 AQUAx study of AAV2-hAQP1 for the treatment of grade 2/3 late radiation-induced...

Global Genomic Medicine Market to reach USD 123 billion by 2035, driven by rising cancer cases and growing adoption of precision medicine.

Austin, United States, May 13, 2026 (GLOBE NEWSWIRE) -- “As per the SNS Insider, the Personalized Retail Nutrition and Wellness Market was valued at USD 4.58 billion in 2025 and is projected to...

Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Nucleic Acid Isolation and Purification Market by Product, Method, Type, Application, End User, Region - Global Forecast to 2030" has been added to ...

IMNN-001 is the First and Only frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with ovarian cancer Enrollment...

Austin, United States, May 06, 2026 (GLOBE NEWSWIRE) -- “According to SNS Insider, the DNA Diagnostics Market size was valued at USD 19.24 Billion in 2025 and is projected to reach USD 40.84 Billion...

LAWRENCEVILLE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company...

Jeremy B. Fitch, MBA, appointed as Chief Business OfficerMichael A. Alrutz, J.D., Ph.D., appointed as General CounselGuy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United...

Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Cat Vaccine Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cat vaccine market has witnessed significant...

VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7J0), a biopharmaceutical company advancing...